IARTIntegra LifeSciences Holdings Corporation

$747M

Q2 2018 Earnings

Healthcare Medical - Devices

Income Statement

Revenue

$366M+29.8% YoY

Gross Profit

$229M62.4% margin

Operating Income

$28M7.5% margin

Net Income

$11M3.1% margin

EPS (Diluted)

$0.14

QoQ Revenue Growth

+2.6%

Cash Flow

Operating Cash Flow

$36M

Free Cash Flow

$16M

Stock-Based Comp.

$5M

Balance Sheet

Total Assets

$3.2B

Total Liabilities

$1.8B

Stockholders' Equity

$1.3B

Cash & Equivalents

$184M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$366M	$282M	+29.8%
Gross Profit	$229M	$183M	+24.8%
Operating Income	$28M	$17M	+62.7%
Net Income	$11M	$11M	+5.0%

Revenue Segments

Codman Specialty Surgical

$240M65%

Orthopedics and Tissue Technologies

$127M35%

Geographic Segments

UNITED STATES

$260M71%

Europe

$51M14%

Asia Pacific

$35M10%

Rest Of World

$20M5%

IART Q2 2018 Earnings — Integra LifeSciences Holdings Corporation Revenue & Financial Results | Market Cap Arena